Pfizer Inc
Pfizer and AstraZeneca announce new investments of practically $1 billion in France
Sopa Images | Lightrocket | Getty Photographs Major healthcare corporations Pfizer and AstraZeneca announced on Sunday new investments in France worthy of a whole of virtually $1 billion, ahead of the get started of this year’s yearly ‘Choose France’ small business summit. Pfizer reported it would devote 500 million euros ($538.5 million) in France to develop up […]
Read More
Moderna says FDA delayed RSV vaccine approval to end of May
Nikos Pekiaridis | Lightrocket | Getty Images Moderna on Friday said the Food and Drug Administration has delayed the approval of its vaccine for respiratory syncytial virus to the end of May due to “administrative constraints” at the agency. The FDA was expected to make a decision on the RSV shot on Sunday. The agency […]
Read More
Novavax signs multibillion-dollar deal with Sanofi to commercialize Covid vaccine, develop combination shots
A health worker prepares a dose of the Novavax vaccine as the Dutch Health Service Organization starts with the Novavax vaccination program on March 21, 2022 in The Hague, Netherlands. Patrick Van Katwijk | Getty Images Novavax on Friday said it has signed a multibillion-dollar deal with French drugmaker Sanofi to co-commercialize the company’s Covid […]
Read More
Shares producing the largest moves midday: Super Micro Computer, Starbucks, Pfizer and additional
Verify out the businesses earning headlines in midday buying and selling: New York Neighborhood Lender — Shares of the crushed-down regional bank popped much more than 31% right after CEO Joseph Otting claimed in a launch , “we have a apparent route to profitability over the pursuing two decades.” The bank on Wednesday posted a […]
Read More
Stocks earning the greatest moves premarket: Pfizer, CVS, Amazon, Starbucks and far more
Check out out the firms generating headlines in premarket trading. Pfizer — Shares climbed a lot more than 2% just after New York City-primarily based Pfizer conquer Wall Street’s initial-quarter income forecast and lifted its complete-calendar year profit advice. The drugmaker now expects modified earnings of $2.15 to $2.35 for each share for the entire-yr, […]
Read More
Pfizer beats revenue estimates, raises profit outlook on cost cuts and strong non-Covid sales
Jakub Porzycki | Nurphoto | Getty Images Pfizer on Wednesday reported first-quarter revenue that beat expectations and hiked its full-year profit outlook, benefitting from its broad cost-cutting program and strong sales of its non-Covid products. The company now expects to book adjusted earnings of $2.15 to $2.35 per share for the fiscal year, up from […]
Read More
Eli Lilly assures investors it can overcome the high-quality problem of too much demand
Eli Lilly ‘s raised guidance stole the show Tuesday, offsetting mixed first-quarter results and propelling shares higher by nearly 6%. The numbers leave little doubt that the long-term Eli Lilly success story remains intact, as demand for its new diabetes and obesity drugs, Mounjaro and Zepbound, outstrips supply. Revenue in the three months ended March […]
Read More
Earnings playbook: Your tutorial to the busiest week of the season, including Apple and Amazon
It can be the busiest 7 days of the earnings year, and it could have significant outcomes for the inventory industry. About 160 S & P 500 companies are slated to put up their outcomes, together with Apple, Amazon and McDonald’s . Pfizer is also on deck. By way of Friday’s close, much more than […]
Read More
FDA approves Pfizer’s first gene therapy for rare inherited bleeding disorder
Pavlo Gonchar | Lightrocket | Getty Images The Food and Drug Administration on Friday approved Pfizer‘s treatment for a rare genetic bleeding disorder, making it the company’s first-ever gene therapy to win clearance in the U.S. The agency greenlit the drug, which will be marketed as Beqvez, for adults with moderate to severe hemophilia B […]
Read More
Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly loss
The Bristol Myers Squibb research and development center at Cambridge Crossing in Cambridge, Massachusetts, on Dec. 27, 2023. Adam Glanzman | Bloomberg | Getty Images Bristol Myers Squibb on Thursday reported first-quarter revenue that topped expectations as its blockbuster blood thinner Eliquis and several new drugs posted sales growth. But the pharmaceutical company swung to […]
Read More